El Hospital Infantil Universitario Niño Jesús es un centro sanitario perteneciente al SERMAS situado en la ciudad de Madrid, frente al parque de El Retiro. Es único en España porque atiende todas las necesidades pediátricas. Se trata del primer hospital pediátrico de España.​

During the past decade, Hospital Infantil Universitario Nino Jesus conducted 91 clinical trials. In the 10-year time frame, 91 clinical trials started and 25 clinical trials were completed, i.e. on average, 27.5% percent of trials that started reached the finish line to date. In the past 5 years, 49 clinical trials started and 17 clinical trials were completed. i.e. 34.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Infantil Universitario Nino Jesus" #1 sponsor was "Eli Lilly and Company" with 10 trials, followed by "Hoffmann-La Roche" with 9 trials sponsored, "Janssen Research & Development, LLC" with 5 trials sponsored, "Pfizer" with 5 trials sponsored and "Rocket Pharmaceuticals Inc." with 5 trials sponsored. Other sponsors include 73 different institutions and companies that sponsored additional 53 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Infantil Universitario Nino Jesus" #1 collaborator was "Hospital Infantil Universitario Niño Jesús, Madrid, Spain" with 5 trials as a collaborator, "Merck Sharp & Dohme LLC" with 3 trials as a collaborator, "ADIR, a Servier Group company" with 2 trials as a collaborator, "Apices Soluciones S.L." with 2 trials as a collaborator and "Germans Trias i Pujol Hospital" with 2 trials as a collaborator. Other collaborators include 34 different institutions and companies that were collaborators in the rest 42 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Infantil Universitario Nino Jesus" are "Solid Tumors" (6 trials), "Cystic Fibrosis" (4 trials), "Acute Lymphoblastic Leukemia" (3 trials), "Acute Myeloid Leukemia" (3 trials) and "Atopic Dermatitis" (3 trials). Many other conditions were trialed in "Hospital Infantil Universitario Nino Jesus" in a lesser frequency.

Most popular intervention types in "Hospital Infantil Universitario Nino Jesus" are "Drug" (78 trials), "Biological" (15 trials), "Other" (15 trials), "Device" (3 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "Cyclophosphamide" (8 trials), "Cytarabine" (7 trials), "Vincristine" (6 trials) and "Baricitinib" (5 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Infantil Universitario Nino Jesus" are 109 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are 59 active trials in "Hospital Infantil Universitario Nino Jesus". 2 are not yet recruiting, 37 are recruiting, 18 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 41 completed trials in Hospital Infantil Universitario Nino Jesus, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Infantil Universitario Nino Jesus, 26 "Phase 1" clinical trials were conducted, 46 "Phase 2" clinical trials and 46 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 8 trials that are defined as “Not Applicable".

Hospital Infantil Universitario Nino Jesus has several departments that took part in Clinical trials: "Hospital Infantil Universitario Niño Jesus; Pediatria Social" - 2 trials